Literature DB >> 2122109

The long-term outcome of patients with glycogen storage diseases.

G P Smit1, J Fernandes, J V Leonard, E E Matthews, S W Moses, M Odievre, K Ullrich.   

Abstract

In this retrospective study from five centres, 139 patients over 10 years of age with glycogen storage disease types I, III, VI and IX are described. Almost half of the patients with glycogen storage disease type Ia had retarded growth and most had hyperlipidaemia. One-third of the patients had adenomas, although none of these showed malignant transformations. With increasing age the growth, liver size and hyperlipidaemia of patients with glycogen storage disease type III improve. However, there was a high incidence of myopathy and cardiomyopathy. Patients with glycogen storage disease types VI and IX had a normal growth pattern after childhood. Hepatomegaly and hypercholesterolaemia, however, were still present in half of the patients.

Entities:  

Mesh:

Year:  1990        PMID: 2122109     DOI: 10.1007/bf01799498

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

Review 1.  Glycogen storage disease: recommendations for treatment.

Authors:  J Fernandes; J V Leonard; S W Moses; M Odièvre; M di Rocco; J Schaub; G P Smit; K Ullrich; P Durand
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

2.  X-chromosomal inheritance of liver glycogenosis with phosphorylase kinase deficiency.

Authors:  F Huijing; J Fernandes
Journal:  Am J Hum Genet       Date:  1969-05       Impact factor: 11.025

3.  Hyperfiltration and renal disease in glycogen storage disease, type I.

Authors:  L Baker; S Dahlem; S Goldfarb; E F Kern; C A Stanley; J Egler; J S Olshan; S Heyman
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

4.  Hepatic adenomata in type Ia glycogen storage disease.

Authors:  C I Coire; A H Qizilbash; M F Castelli
Journal:  Arch Pathol Lab Med       Date:  1987-02       Impact factor: 5.534

5.  Renal disease in type I glycogen storage disease.

Authors:  Y T Chen; R A Coleman; J I Scheinman; P C Kolbeck; J B Sidbury
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

Review 6.  Glycogen storage disease type Ib.

Authors:  J Schaub; K Heyne
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

  6 in total
  14 in total

1.  Orthotopic liver transplantation in liver-based metabolic disorders.

Authors:  A P Mowat
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

2.  [Polyglycosan body myopathy].

Authors:  M Jeub; K Kappes-Horn; C Kornblum; D Fischer
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

3.  Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.

Authors:  Li-Ya Chiu; Priya S Kishnani; Tzu-Po Chuang; Cheng-Yang Tang; Cheng-Yuan Liu; Deeksha Bali; Dwight Koeberl; Stephanie Austin; Keri Boyette; David A Weinstein; Elaine Murphy; Adam Yao; Yuan-Tsong Chen; Ling-Hui Li
Journal:  J Gastroenterol       Date:  2013-10-16       Impact factor: 7.527

4.  Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient.

Authors:  Christiaan P Sentner; Kadir Caliskan; Wim B Vletter; G Peter A Smit
Journal:  JIMD Rep       Date:  2011-12-13

5.  Different clinical aspects of debrancher deficiency myopathy.

Authors:  S Kiechl; U Kohlendorfer; C Thaler; D Skladal; M Jaksch; B Obermaier-Kusser; J Willeit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

6.  Blood lipids and endothelial function in glycogen storage disease type III.

Authors:  E Hershkovitz; A Donald; M Mullen; P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

7.  Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia.

Authors:  David A Weinstein; Catherine E Correia; Thomas Conlon; Andrew Specht; John Verstegen; Karine Onclin-Verstegen; Martha Campbell-Thompson; Gurmeet Dhaliwal; Layla Mirian; Holly Cossette; Darin J Falk; Sean Germain; Nathalie Clement; Stacy Porvasnik; Laurie Fiske; Maggie Struck; Harvey E Ramirez; Juan Jordan; Karl Andrutis; Janice Y Chou; Barry J Byrne; Cathryn S Mah
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

8.  Bone mineralisation in type 1 glycogen storage disease.

Authors:  P J Lee; J S Patel; M Fewtrell; J V Leonard; N J Bishop
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

9.  Clinical manifestations and growth of patients with urea cycle disorders in Japan.

Authors:  Kimitoshi Nakamura; Jun Kido; Shirou Matsumoto; Hiroshi Mitsubuchi; Fumio Endo
Journal:  J Hum Genet       Date:  2016-03-03       Impact factor: 3.172

10.  Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time.

Authors:  Shawyntee M Vertilus; Stephanie L Austin; Kimberly S Foster; Keri E Boyette; Deeksha S Bali; Jennifer S Li; Priya S Kishnani; Stephanie Burns Wechsler
Journal:  Genet Med       Date:  2010-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.